Posted on 4 月 28, 20204/28/20
ICER Analysis of Vertex’s 4 CFTR Modulators Hails Benefit of Trikafta but Suggests 73% Discount
Posted on 4 月 27, 20204/27/20
SPOPTIMIZER by EVERSANA™
Posted on 4 月 24, 20204/24/20
EVERSANA establishes data and analytics offering, appoints Brigham Hyde president
Posted on 4 月 23, 20204/23/20
Czech Republic Allows Pre-Authorized Use of Zolgensma
Posted on 4 月 23, 20204/23/20
EVERSANA™ launches data & analytics business to drive next-generation integrated commercial services
Posted on 4 月 13, 20204/13/20
Japan’s PMDA Evaluates Side Effects of Insulins, Cancer Drugs
Posted on 4 月 8, 20204/8/20
FDA Grants Priority Review to Merck’s Keytruda, Use Based on Biomarker Regardless of Tumor Type
Posted on 4 月 7, 20204/7/20
EMA to Mitigate Drug Supply Shortages Through i-SPOC System
Posted on 4 月 2, 20204/2/20
